NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/31/2023
Back to search
Official data from USPTO
AVISCERA BIOSCIENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AVISCERA BIOSCIENCE
ST13
US500000085679104Class
1
Filing
85679104
Registration
4320226
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
03/31/2023
Trademark type
Word
Nice classes
1
Filing date
07/17/2012
Registration date
04/16/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/31/2023
Last transaction
03/31/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
07/13/2012
First use in commerce
07/13/2012
Drawing code
4
Owner type
03
Owner location
Santa Clara, CA
Examiner
CRAWFORD, MARY
Law office
L20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Aviscera Bioscience, Inc.
Representatives
Hong Shen
Technical classification
Nice Classes
Class 1
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical and biochemical reagents for research usefor diagnostic clinical or medical laboratory use and for testing the sterility of pharmaceuticalimmunoassays and biochemistry assaysprotein arrays for medical researchpeptide substrates for use in analyzing and detecting certain toxins for research use; diagnostic immunoassay and biochemistry assay kits comprised of reagents and assays for detection of natural or recombinant proteinspeptidesenzymeshormonesbiochemical molecules for clinical or medical laboratory use; chemicalsbiochemistry buffer solutionsassay diluent solutionspurification solutionsenzymes substrates for use in analytical chemistry; recombinantisolated and synthetic proteinspeptides and enzymesrecombinantisolated and synthetic proteins arrays for scientific and medical researchpeptide substrates used in analyzing and detecting certain toxins for laboratory or research useenzymes for scientific and research purposes; chemical preparations for purification of proteinspeptidesantibodiesenzymes for scientific purposes; affinity purification kits containing pre-packed columnschemicals and solid support phase reagents for use in the purification of proteins; protein arrays comprised of proteinpeptides and antibodies with fluorescent dyebiotin and enzymes for scientific and medical research; solid or liquid phase support enzyme-linked immunosorbent assay kits comprised of assaysdiagnostic primary antibody and antibody arraysdiagnostic antibodies for western blot analysis for detection of immunogens or proteins in circulating samplescellstissues slides and tissues homogenates for scientific or research use; protein arrays and protein on solid phase support assay kits comprised of protein arrays and reagents for testing protein interactionreceptor bindingsoluble protein ligand or enzymes for scientific and medical research; diagnostic preparationsimmunoassay kits consisting of purified polyclonal antibodymonoclonal antibodysolid phase support enzymes and peptidesbufferschemical diluent solutionsenzymes substratesreagents for use in diseases biomarker tests for scientific or research purposes
Publications
History of USPTO decisions and trademark events.
36 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/31/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/31/2023
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
03/28/2023
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
03/28/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/28/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
09/15/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/16/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/23/2018
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/23/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/23/2018
E815
TEAS SECTION 8 & 15 RECEIVED
07/11/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/11/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/16/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
04/16/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/29/2013
PUBO
PUBLISHED FOR OPPOSITION
01/29/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/09/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/21/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/19/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/07/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/06/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/06/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/06/2012
GNRT
NON-FINAL ACTION E-MAILED
12/06/2012
CNRT
NON-FINAL ACTION WRITTEN
12/06/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/23/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/23/2012
ALIE
ASSIGNED TO LIE
11/23/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/15/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/14/2012
GNRT
NON-FINAL ACTION E-MAILED
11/14/2012
CNRT
NON-FINAL ACTION WRITTEN
11/14/2012
DOCK
ASSIGNED TO EXAMINER
11/09/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/24/2012
NWAP
NEW APPLICATION ENTERED
07/20/2012
Continuous trademark protection
Get notified about every new filing that threatens AVISCERA BIOSCIENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.